NEW YORK (GenomeWeb News) – Celera subsidiary Berkeley HeartLab said yesterday that Geisinger Medical Center and a clinical lab service recently started by Geisinger Health System will use some of its cardiovascular diagnostic tests and services.

Under a co-marketing agreement, Geisinger Health System's Proven Diagnostics lab service will provide BHL's 4myheart cardiovascular disease management program and select tools from BHL's menu of cardiovascular tests and services. Proven Diagnostics and Geisinger Medical Center also will have access to BHL's KIF6 test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.